PCAS Company Profile: Acquisition & Investors

PCAS Overview

Founded
1962

Status
Acquired/Merged

Employees
1,200

Latest Deal Type
Buyout/LBO

Financing Rounds
2

Investments
3

PCAS General Information

Description

PCAS SA is in the development, manufacturing and marketing of specialty chemicals. The company's products include synthesized pharmaceutical products and fine chemicals. It also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).

Contact Information

Website

www.pcas.com

Formerly Known As

Produits Chimiques Auxiliaires Et De Synthese

Ownership Status

Acquired/Merged
(Operating Subsidiary)

Financing Status

Private Equity-Backed

Primary Industry

Industrial Chemicals

Parent Company

Seqens

Former Stock Listing

PCA

Primary Office

21 Chemin De La Sauvegarde
69134 Ecully
France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PCAS Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore PCAS‘s full profile, request access.

Request a free trial

PCAS Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last
Financing
Details

PCAS SA is in the development, manufacturing and marketing of specialty chemicals. The company's products include synthe

Industrial Chemicals

Ecully, France

1,200 As of 2023

000000000000

000000

empor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis

0000000000 000000000

New York, NY

0000 As of 0000

00.00

000000000 00.00

000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur

0000000000 000000000

Helsinki, Finland

0000 As of 0000

00000

0000 0000-00-00

000000000 00000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PCAS Competitors (14)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Minerals Technologies	Corporation	New York, NY	0000	00.00	000000000	00.00
000000	Corporation	Helsinki, Finland	0000	00000	000000000	00000
00 00000	Private Equity-Backed	Schenectady, NY	0000	000.00	000000000	000.00
00 000000000	Private Equity-Backed	Monheim am Rhein, Germany	0000		000000&0
0000000 00000000 0	Corporation	Kingsport, TN	00000		00000000

You’re viewing 5 of 14 competitors. Get the full list »

PCAS Patents

73
Total Documents Applications and Grants
000
Total Patents Families
3
Granted
1
Pending
000
Expiring in next 12 mo

PCAS Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)	Citations
EP-3907213-A1	Processes for the production of isomerically pure or enriched cis-clomiphene	Inactive	04-May-2020	0000000000	0
US-20210340096-A1	Processes for the production of isomerically pure or enriched cis-clomiphene	Active	04-May-2020	0000000000
US-11572333-B2	Processes for the production of isomerically pure or enriched cis-clomiphene	Active	04-May-2020	0000000000	0
EP-4146620-A1	Processes for the production of isomerically pure or enriched cis-clomiphene	Pending	04-May-2020	0000000000
EP-3707268-A1	Enzymatic method for forming estolides	Pending	08-Nov-2017	C12P7/625